• Introduction
  • Research
  • Teaching
  • Funding
  • Publications
  • Awards
  • Honor Reward
  • Admission
Wuying头像

Wuying

Associate professor 100029 

Department: Field:

Email: uvanwy@buct.edu.cn Office:

ORCID: DBLP:

10 Visits

Introduction

Wu Ying, Associate Professor at Beijing University of Chemical Technology, holds a Doctor of Science degree and is recognized as a Boxue Young Scholar at the institution. She serves as a Young Editorial Board Member for journals including Biomedical Technology and Interdisciplinary Medicine. Dr. Wu received her Ph.D. in Analytical Chemistry from Fuzhou University. Her current research focuses on stimulus-responsive biomaterials and molecular probes for tumor diagnosis and therapy. She has achieved a series of original research outcomes in the fields of optical imaging, nanomaterial design and synthesis, and the development of probes for cancer radiation diagnostics and treatment. To date, she has published 54 SCI-indexed papers in high-impact international journals spanning chemistry, materials science, and biomedical engineering, with a cumulative impact factor of 595. Among these publications, she has been the first or corresponding author on articles in prestigious journals such as Angewandte Chemie International Edition, Nano Today, and ACS Nano. More than ten of her works have appeared in Nano Letters and other leading journals, resulting in an H-index of 24 and over 1,800 citations. Additionally, she has filed eight national invention patents. Dr. Wu has led multiple research projects, including those funded by the National Natural Science Foundation of China (for Young Scientists), the Beijing Public Welfare Fund, the Regional Joint Fund of the National Natural Science Foundation of China, and the General Program of the National Natural Science Foundation of China. Her contributions have been recognized with awards including the Second Prize of the Chinese Medical Science and Technology Award, the First Prize of the Scientific Progress Award from the Shandong Biomedical Engineering Society, and the Second Prize of the Natural Science Award from the Shandong Chemical and Chemical Engineering Society.

Education

Work Experience

Social Position

Social Activities

Research

(1) In vivo imaging and molecular measurement: Accurate monitoring of the temporal and spatial distribution, function, and interaction mode of disease-related marker molecules in deep tissues are a crucial prerequisite for further elucidating the pathogenic mechanism, diagnosing and treating diseases, as well as predicting treatment efficacy. The probe enables exploration and precise description of the in vivo spatial and temporal distribution of molecules while establishing the structure-activity relationship between them and the occurrence and progression of diseases.
(2) The novel technology for disease diagnosis and treatment: By employing biological molecular response probes for quantitative detection and dynamic monitoring information on early markers in disease diagnosis and treatment, this approach reveals both the underlying mechanisms driving disease development as well as changes occurring during diagnosis/treatment processes. It provides a new avenue towards efficient disease diagnosis and treatment.

Teaching

Analytical chemistry

New techniques for chemical and biological imaging

Postgraduates

Funding

1. National Natural Science Foundation Committee, Youth Fund, as PI, in research.

2. Beijing Natural Science Foundation Committee, General Program, as PI, concluded.

3. China Postdoctoral Science Foundation, Special Funding (Pre-Station), as PI, concluded.

4. China Postdoctoral Science Foundation, General Program, as PI, concluded.

5.National Natural Science Foundation of China, Joint Fund Project, as participant, in research.

6.National Natural Science Foundation of China, General Program, as participant, in research.

Vertical Project

Horizontal Project

Publications

1.         Wu, Y.#; Wang, Q.#; Zhu, K.; Zheng, L.; Li, Q.; Huang, W.; Du, Y.; Chen, L.*; Song, J.*; Yang, H.* Quantitative Tracking of Apoptotic Caspase‐3 In Vivo for Early Evaluation of Radiation Therapy Efficacy. Angewandte Chemie International Edition2025, 64 (34), e202502811.

2.         Gao, Y.; Lin, Z.; Yang, Y.; Liu, C.; Du, W.; Tian, S.; Jiang, P.; Lin, Y.; Chen, C.; Wu, Y.#; et al. X‐Ray‐Activated Self‐Calibrating Second Near‐Infrared Fluorescent Probes for Precision Radiosensitization Therapy in Esophageal Cancer. Advanced Functional Materials 2025, DOI: 10.1002/adfm.202512622.

3.         Wu, Y.; Su, L.; Yuan, M.; Chen, T.; Ye, J.; Jiang, Y.; Song, J.*; Yang, H.*, In Vivo X-ray Triggered Catalysis of H2 Generation for Cancer Synergistic Gas Radiotherapy. Angewandte Chemie International Edition 2021, 60 (23), 12868-12875.

4.         Wang, S.; Liu, W.; Cao, Y.; Wang, J.; Zhu, K.; Li, Z.; Cao, J.; Mo, C.; Chen, Q.; Huang, W.; Wu, Y.*; Chen, L.*; Song, J.* Janus Nanoprobe with Dual-Modal NIR-II Fluorescence/Photoacoustic Imaging for Precision Cancer Radiosensitizing Therapy. ACS Applied Materials & Interfaces2025, 17 (20), 29266–29275.

5.         Mo, C.; Fu, L.; Zou, H.; Liu, C.; Zhu, K.; Cao, J.; Wang, J.; Zhou, H.; Wang, D.; Sun, Y.; Wu, Y.*; Li, Q.*; Song, J.*, Near-infrared light-induced self-assembled lanthanide nanoparticles for boosted radiosensitization and persistent tumor therapy monitoring. Nano Todays 2025, 64, 102782.

6.         Su, L.#; Zhu, K.#; Ge, X.#; Wu, Y.*; Zhang, J.; Wang, G.; Liu, D.; Chen, L.*; Li, Q.; Chen, J.; Song, J.*, X-ray Activated Nanoprodrug for Visualization of Cortical Microvascular Alterations and NIR-II Image-Guided Chemo-Radiotherapy of Glioblastoma, Nano letters 2024, 24: 3727-3736.

7.         Mo, C.; Zhang, W.; Zhu, K.; Du, Y.; Huang, W.*; Wu, Y.*; Song, J.*, Advances in Injectable Hydrogels Based on Diverse Gelation Methods for Biomedical Imaging, Small Methods 2024, 8 (12), 2400076.

8.         Liu, X.#; Wang, J.#; Wu, Y.*; Wu, M.*; Song, J.*, Ultrasound Activated Probe for Disease Imaging and Therapy In-Vivo. Advanced Drug Delivery Reviews 2024, 205, 115158.

9.         Wu, Y.; Yuan, M.; Song, J.*; Chen, X.*; Yang, H.*, Hydrogen Gas from Inflammation Treatment to Cancer Therapy. ACS Nano 2019, 13 (8), 8505-8511.

10.     Wu, Y.; Zhu, K.; Zhang, X.; Du, W.; Song, J.*; Yang, H.*, Emerging Plasmonic Nanoparticles and Their Assemblies for Cancer Radiotherapy. Advanced Drug Delivery Reviews 2023, 194, 114710.

11.       Wu, Y.; Guo, T.; Qiu, Y.; Lin, Y.; Yao, Y.; Lian, W.; Lin, L.; Song, J.*; Yang, H.*, An Inorganic Prodrug, Tellurium Nanowires with Enhanced ROS Generation and GSH Depletion for Selective Cancer Therapy. Chemical Science2019, 10 (29), 7068-7075.


Awards

1. Wu Ying (4/10); Key Technological Innovation and Application of Precision Radiotherapy Schemes Based on the Characteristics of Esophageal Squamous Cell Carcinoma in China, Chinese Medical Association, Science and Technology, Second Prize, 2025
2. Wu Ying (4/7); Molecular Biomarker Characteristics of Esophageal Cancer and Clinical Research on Individualized Precision Radiotherapy, Fujian Medical Association, Medical Science and Technology Award, Second Prize at Provincial and Ministerial Level, 2025
3. Wu Ying (3/9); Precision Diagnosis and Treatment of Tumors Guided by Responsive In Situ Molecular Imaging, Shandong Society of Biomedical Engineering, Science and Technology Progress, First Prize, 2024
4. Wu Ying (6/9); Construction of Functionalized Deep Eutectic Solvents and Mechanism Research in the Preparation of Fine-Structured Nanomaterials, Shandong Chemical Industry and Chemical Engineering Society, Natural Science Award, Second Prize, 2024

Patent

Honor Reward

Admissions Information